Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Antonio Blasco (), Pablo Lázaro (), Teresa Caballero () and Mar Guilarte ()

Health Economics Review, 2013, vol. 3, issue 1, 1-11

Abstract: Costs related to the management of acute HAE attacks with C1 inhibitor deficiency may be substantially reduced through interventions targeting home treatment by training patients to self-administer icatibant. Copyright Blasco et al; licensee Springer. 2013

Keywords: C1-INH; Hereditary angioedema; Economic evaluation; Icatibant (search for similar items in EconPapers)
Date: 2013
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1186/2191-1991-3-2 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:3:y:2013:i:1:p:1-11:10.1186/2191-1991-3-2

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/2191-1991-3-2

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().